Browse > Article

Flavonols from Houttuynia cordata with Protein Glycation and Aldose Reductase Inhibitory Activity  

Jang, Dae-Sik (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Kim, Jong-Min (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Lee, Yun-Mi (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Yoo, Jeong-Lim (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Kim, Young-Sook (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Kim, Joo-Hwan (Department of Life Science, Daejeon University)
Kim, Jin-Sook (Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine)
Publication Information
Natural Product Sciences / v.12, no.4, 2006 , pp. 210-213 More about this Journal
Abstract
A 4,5-dioxoaporphine type alkaloid, cepharadione B (1), a phenolic acid, protocatechuic acid (2), and flavonols, quercetin (3), afzelin (4), and quercitrin (5), were isolated from the EtOAc-soluble extract of the whole plants of Houttuynia cordata. All the isolates (1-5) were subjected to in vitro bioassays to evaluate advanced glycation end products (AGEs) formation and rat lens aldose reductase (RLAR) inhibitory activity. The three flavonols 3-5 exhibited a significant inhibitory activity on AGEs formation with $IC_{50}$ values of 66.9, 58.9, and $32.3{\mu}M$, respectively. While the two flavonol rhamnosides 4 and 5 showed a remarkable inhibitory activity against RLAR with $IC_{50}$ values of 0.81 and $0.16{\mu}M$, respectively.
Keywords
Houttuynia cordata; Saururaceae; flavonols; diabetic complications; AGEs; aldose reductase;
Citations & Related Records

Times Cited By SCOPUS : 5
연도 인용수 순위
1 Ahmed, N., Advanced glycation endproducts-role in pathology of diabetic complications, Diabetes Res. Clin. Practice 67, 3-21 (2005)   DOI   ScienceOn
2 Ji, B. and Zhao, K., Clinical application of Houttuynia cordata injection. Chin. Med. Pharm. J. 2, 14-16 (2003)
3 Kim, H.-Y. and Oh, J.H., Screening of Korean forest plants for rat lens aldose reductase inhibition. Biosci. Biotechnol. Biochem. 63, 184-188 (1999)   DOI   ScienceOn
4 Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z.H., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A,, and Vlassara, H.N., Advanced glycosylation end products in patients with diabetic nephropathy. N. Eng. J. Med. 325, 836-842 (1993)   DOI   ScienceOn
5 Park, J.-C., Hur, J.-M., Park, J.-W., Park, S.-J., Lee, J.-H., Sung, N.-J., Choi, M.-R., Song, S.-H., Kim, M.-S., and Lee, J.-W., The effects of Houttuynia cordata on the hepatic bromobenzene metabolizing enzyme system in rats and isolation of phenolic compounds. Kor. J. Pharmacog. 31, 228-234 (2000)   과학기술학회마을
6 Yabe-Nishimura, C., Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50, 21-33 (1998)
7 Vinson, J.A. and Howard III, T.B., Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7, 659-663 (1996)   DOI   ScienceOn
8 Jang, D.S., Kim, J.M., Lee, Y.M., Kim, Y.S., Kim, J.-H., and Kim, J.S., Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54, 1315-1317 (2006)   DOI   ScienceOn
9 Forbes, J.M., Cooper, M.E., Oldfield, M.D., and Thomas, M.C., Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14, S254-S258 (2003)   DOI
10 Matsuda, H., Morikawa, T., Toguchida, I., and Yoshikawa, M., Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 50, 788-795 (2002)   DOI   ScienceOn
11 Matsuda, H., Wang, T., Managi, H., and Yoshikawa, M., Structural requirements of tlavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11, 5317-5323 (2003)   DOI   ScienceOn
12 Probstle, A., Neszmely, A., Jerkovich, G., Wagner, H., and Bauer, R., Novel pyridine and 1,4-dihydropyridine alkaloids from Houttuynia cordata. Nat. Prod. Lett. 4, 235-240 (1994)   DOI   ScienceOn
13 Rahbar, S., Yerneni, K.K., Scott, S., Gonzales, N., and Lalezari, I., Novel inhibitors of advanced glycation endproducts (Part II). Mol. Cell Biol. Res. Commun. 3, 360-366 (2000)   DOI   ScienceOn
14 Larkins, R.G. and M.E. Dunlop., The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35, 499-504 (1992)   DOI
15 Kalousova, M., Zima, T., Tesar, V., Stipek, S., and Sulkova, S., Advanced glycation end products in clinical nephrology. Kidney Blood Press Res. 27, 18-28 (2004)   DOI   ScienceOn
16 Shanghai Science and Technological Publisher, The dictionary of Chinese Drugs Vol. 1, Shougakukan, Tokyo, 1985, p. 507
17 Kim, S.-K., Ryu, S.Y., No, J., Choi, S.H., and Kim, Y.S., Cytotoxic alkaloids from Houttuynia cordata. Arch. Pharm. Res. 24, 518-521 (2001)   DOI   ScienceOn
18 Liu, Y.L. and Deng, Z.F., Investigation of the chemical constituents of the essential oil of Houttuynia cordata Thunb. Acta Botanica Sinica 21, 244-249 (1979)
19 Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A., and Itoh, M., Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta 1425, 577-586 (1998)   DOI   ScienceOn
20 Beyer-Mears, A. and Cruz, E., Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes 34, 15-21 (1985)   DOI   ScienceOn